Hands4U,
does it really help with Prevention of hand eczema in healthcare workers?
research showsThe grade is D. In a cluster-randomized trial of 48 departments and 1,649 baseline respondents, 12-month self-reported hand eczema was 11.3% with the program versus 9.7% with control; adjusted OR 1.45 (95% CI 1.03–2.04), an absolute increase in reporting of 1.6 points. Prevention was not shown, and true disease harm cannot be determined because unmasked self-report was vulnerable to differential reporting.
ads claimLess hand washing or more moisturizer use cannot be converted into successful eczema prevention. Preventive behavior improved, but the prespecified self-reported eczema outcome did not decline. Whether more reports represented more true disease cannot be determined because differential reporting is plausible.
Useful facts when choosing a product
- The intervention combined education, participatory working groups, role models, reminders, and a leaflet at the department level.
- Control departments also received the same leaflet, so this was not a completely untreated control.
- Twelve-month eczema was self-reported and 1.6 percentage points higher with the program.
Chamgap Semantic Classification Code
Candidate index · review held
UNK.hands4u-multifaceted-guideline-implementation-program.UNK.hand-eczema-in-healthcare-workers.prevent.UNKUnknown > Hands4U multifaceted guideline-implementation program > Unknown > hand eczema in healthcare workers > Occurrence-prevention claim > Unknown
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
Hands4U cluster-randomized 48 departments at three Dutch university hospitals: 23 intervention and 25 control. Baseline respondents numbered 876 and 773; 12-month respondents numbered 611 and 486. Self-reported hand eczema at 12 months was 69/611 (11.3%) versus 47/486 (9.7%), adjusted OR 1.45 (95% CI 1.03–2.04), absolute difference +1.6 points. Linear and logistic multilevel analyses with random coefficients modeled four levels: repeated measurements, workers, departments, and hospitals. The two axis-6 B2 limitations were ① an unmasked subjective endpoint and ② substantial attrition, with more than 30% nonresponse at 12 months. The article reports a ZONMW grant and no company funding statement.
Why this is classified as D (30)
One publicly funded cluster trial did not show prevention and produced more self-reports, but an unmasked subjective endpoint and more than 30% 12-month nonresponse prevent a judgment of true disease harm, giving D with 30 points.
Counterpoint. The program did not show prevention, but more self-reports are not conclusive evidence that it caused eczema. Increased symptom awareness and differential reporting must accompany interpretation.
Rejudgment record. Cross-check applied — Combines the higher self-reported eczema result with the differential-reporting explanation and limitations from lack of masking and substantial missingness
| Endpoint | P | Symptom or function itself is the target - including patient reports and performance tests |
| Replication | R1 | Single confirmatory trial |
| Independence | I2 | Decisive evidence is publicly or non-profit funded |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
Stored derived and displayed grades match; this is not a current recalculation or validity check (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Prevention of hand eczema at 12 months | D | Rates were 11.3% versus 9.7%; prevention was absent and self-report was more frequent. |
| Improved implementation of preventive behavior | B | Less hand washing and greater moisturizer and cotton-underglove use were significant. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| van der Meer EWC et al. 2015 Hands4U | Cluster-randomized trial of 48 departments at three Dutch hospitals | 1,649 baseline respondents, 876 intervention and 773 control; 1,097 responded at 12 months, 611 versus 486 | Grant from the Netherlands Organization for Health Research and Development (ZONMW) | Twelve-month prevalence of self-reported hand eczema during the preceding three months | 69/611 (11.3%) versus 47/486 (9.7%); adjusted OR 1.45 (95% CI 1.03–2.04), absolute difference +1.6 points; hand-washing, moisturizer, and cotton-underglove behavior improved | Single publicly funded cluster trial; unmasked self-report and substantial missingness |
Receipt — 1 References
All 1 cited sources were verified for existence at the original page (as of 2026-08-18).
Final verification and publication gate: Codex · Evidence date: 2026-08-18 · Corrections: none
Cite this verdict
[Chamgap] Hands4U x prevention of hand eczema in healthcare workers — Evidence Grade D·30. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/skin-hair/hands4u-healthcare-worker-hand-eczema-prevention/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.